Dr. Menon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1144 Eastlake Ave E, Seattle WA
Seattle, WA 98109Phone+1 855-557-0555- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2004 - 2007
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2004
- University of ConnecticutInternship, Internal Medicine, 2001 - 2002
- Stanley Medical College SMCClass of 1999
Certifications & Licensure
- WA State Medical License 2022 - 2025
- ID State Medical License 2024 - 2025
- WI State Medical License 2010 - 2023
- MN State Medical License 2003 - 2012
- TX State Medical License 2010 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 107 citationsAdvances in Cancer Immunotherapy in Solid Tumors.Smitha Menon, Sarah Shin, Grace K. Dy
Cancers. 2016-11-24 - 92 citationsComprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ HybridizationSiraj M. Ali, Thomas A. Hensing, Alexa B. Schrock, Justin M. Allen, Eric M. Sanford
The Oncologist. 2016-06-01 - 47 citationsPlacebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome...Sherry L. Wolf, Rui Qin, Smitha Menon, Kendrith M. Rowland, Sachdev P. Thomas
Journal of Clinical Oncology. 2010-12-10
Professional Memberships
- Member
Hospital Affiliations
- Fred Hutchinson Cancer CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: